Latest news
Did Stronger Q2 Earnings and Lowered 2026 Guidance Just Recast Exelixis' (EXEL) Oncology Narrative? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 18:39:21 GMTAmundi Sells 121,348 Shares of Exelixis, Inc. $EXEL - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:09:18 GMTExelixis (NASDAQ:EXEL) Lowered to "Buy" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:04 GMTQuantinno Capital Management LP Boosts Holdings in Exelixis, Inc. $EXEL - MarketBeatMarketBeat · Fri, 07 Aug 2026 12:25:46 GMTEXELIXIS INC EXELIXIS ORD SHS (0IJO.L) Q4 FY2025 earnings call transcript - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:55:01 GMTEXELIXIS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM - BitgetBitget · Fri, 07 Aug 2026 04:55:12 GMTExelixis (EXEL) Is Down 6.7% After Cutting 2026 Revenue Outlook Amid Oncology Investment Pivot - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 02:15:00 GMTWhy Exelixis Is Dropping 7.4%: Truist Securities Maintains Hold - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 23:20:22 GMT